A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Publié en August 2013 Chest

What about targeting smooth muscle remodeling in severe asthma?

Previous publication

Airway smooth muscle in asthma: just a target for bronchodilation?

Next publication